Eva Hambruch

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

Philipp Schwabl, Eva Hambruch, Berit Seeland et al. · Journal of Hepatology · 2016 · 168 citations · Full text

Membrane Association of the Cycling Peroxisome Import Receptor Pex5p

Daniela Kerssen, Eva Hambruch, Wibke Klaas et al. · Journal of Biological Chemistry · 2006 · 110 citations · Full text

Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (−/−) Mice

Eva Hambruch, Shinobu Miyazaki‐Anzai, Ulrike K. Hahn et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 98 citations · Full text

A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes

Alexander Neuhaus, Hamed Kooshapur, Janina Wolf et al. · Journal of Biological Chemistry · 2014 · 69 citations · Full text

Protein Function, Protein Assembly, Biochemistry +9

The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model

Philipp Schwabl, Eva Hambruch, Grant R. Budas et al. · Biomedicines · 2021 · 65 citations · Full text